Nd Pharma & Biotech Ltd
08273797
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/10/2024
total exemption full
Next accounts due
31/07/2026
Confirmation statement
Last: 17/10/2025
Due 31/10/2026
Industry
Officers
secretary · Since 08/06/2022
Persons with Significant Control
Dr. Jose Manuel Lopez
Spanish · Spain · Age 59
87, Chancery Lane, London, WC2A 1ET
Notified 01/06/2016
CompanyRankvs 253+ SIC 20590 peers74
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/10/2024
Net Worth
£211.2M
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£209.7M
Working capital
Current Assets
£210.0M
Current Liabilities
£311k
Fixed Assets
£1.5M
Debtors
£210.0M
Tax at Year End(2021)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 675.56 | -£1k |
| 2023 | 683.21 | -£1k |
| 2022 | 685.85 | -£2k |
| 2021 | 690.95 | +£1.2M |
| 2020 | — | +£0 |
| 2019 | — | +£0 |
Derived from filed accounts. Not audited figures.